New England Research & Management, Inc. Dexcom Inc Transaction History

New England Research & Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	BUY	$110.31 - $140.45 $431,863 - $549,861	3,915 New	3,915 $444,000
Q4 2023 Feb 06, 2024	BUY	$75.49 - $124.16 $222,695 - $366,272	2,950 New	2,950 $366,000
Q3 2022 Oct 06, 2022	BUY	$76.35 - $94.18 $197,746 - $243,926	2,590 New	2,590 $209,000
Q2 2022 Jul 20, 2022	SELL	$67.99 - $132.89 $31,275 - $61,129	-460 Closed	0 $0
Q3 2021 Oct 08, 2021	SELL	$106.71 - $143.18 $86,968 - $116,691	-815 Reduced 63.92%	460 $252,000
Q2 2021 Jul 15, 2021	SELL	$80.99 - $107.93 $2,024 - $2,698	-25 Reduced 1.92%	1,275 $544,000
Q4 2020 Jan 07, 2021	BUY	$78.0 - $104.5 $101,400 - $135,850	1,300 New	1,300 $481,000
Q2 2019 Jul 09, 2019	SELL	$27.84 - $38.92 $70,992 - $99,246	-2,550 Closed	0 $0
Q1 2019 Apr 03, 2019	BUY	$28.07 - $38.18 $71,578 - $97,359	2,550 New	2,550 $304,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

Stay updated on New England Research & Management, Inc. with notifications on news.